Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1987 6
1988 3
1989 5
1991 5
1992 6
1993 8
1994 3
1995 6
1996 7
1997 7
1998 6
1999 5
2000 10
2001 3
2002 3
2003 4
2004 2
2005 3
2006 6
2007 6
2008 1
2009 3
2010 2
2011 2
2012 3
2013 2
2014 4
2015 7
2016 9
2017 4
2018 5
2019 2
2020 2
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
van der Palen J, Thomas M, Chrystyn H, Sharma RK, van der Valk PD, Goosens M, Wilkinson T, Stonham C, Chauhan AJ, Imber V, Zhu CQ, Svedsater H, Barnes NC. van der Palen J, et al. Among authors: barnes nc. NPJ Prim Care Respir Med. 2016 Nov 24;26:16079. doi: 10.1038/npjpcrm.2016.79. NPJ Prim Care Respir Med. 2016. PMID: 27883002 Free PMC article. Clinical Trial.
Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, Islam K, McLaughlin D, Bhowmik A, Timms PM, Rajakulasingam RK, Rowe M, Venton TR, Choudhury AB, Simcock DE, Wilks M, Degun A, Sadique Z, Monteiro WR, Corrigan CJ, Hawrylowicz CM, Griffiths CJ. Martineau AR, et al. Among authors: barnes nc. Lancet Respir Med. 2015 Feb;3(2):120-130. doi: 10.1016/S2213-2600(14)70255-3. Epub 2014 Dec 2. Lancet Respir Med. 2015. PMID: 25476069 Clinical Trial.
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Pascoe S, et al. Among authors: barnes nc. Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12. Lancet Respir Med. 2015. PMID: 25878028 Clinical Trial.
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC; International Mepolizumab Study Group. Flood-Page P, et al. Among authors: barnes nc. Am J Respir Crit Care Med. 2007 Dec 1;176(11):1062-71. doi: 10.1164/rccm.200701-085OC. Epub 2007 Sep 13. Am J Respir Crit Care Med. 2007. PMID: 17872493 Clinical Trial.
Thoracoscopy.
Davidson AC, Sheldon CD, Barnes NC. Davidson AC, et al. Among authors: barnes nc. Respir Med. 1993 Apr;87(3):236-7. doi: 10.1016/0954-6111(93)90108-c. Respir Med. 1993. PMID: 8497707 No abstract available.
Interpreting patient-reported outcomes from clinical trials in COPD: a discussion.
Jones PW, Rennard S, Tabberer M, Riley JH, Vahdati-Bolouri M, Barnes NC. Jones PW, et al. Among authors: barnes nc. Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3069-3078. doi: 10.2147/COPD.S117378. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27994447 Free PMC article. Review.
146 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page